These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 13781854)

  • 1. [Histo-serological studies with fluorescein-labeled anticomplement. Demonstration of complement-binding substances in amyloid].
    VOGT A; KOCHEM HG
    Z Zellforsch Mikrosk Anat; 1960; 52():640-52. PubMed ID: 13781854
    [No Abstract]   [Full Text] [Related]  

  • 2. [Histological demonstration of liverspecific antigens and their disappearance in hepatoma with the aid of fluorescein-labelled anticomplement].
    FISCHER C; WEILER E
    Z Krebsforsch; 1962; 64():441-7. PubMed ID: 13893112
    [No Abstract]   [Full Text] [Related]  

  • 3. [The demonstration of fixed complement with marked anticomplement].
    KLEIN P; BURKHOLDER P
    Schweiz Z Pathol Bakteriol; 1959; 22():729-31. PubMed ID: 14409699
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the specificity of the demonstration of bound complement with fluoresceinlabelled anticomplement].
    MUELLER F; GIESE G; RICKEN D
    Z Hyg Infektionskr; 1961; 147():434-46. PubMed ID: 13773480
    [No Abstract]   [Full Text] [Related]  

  • 5. [On light optical demonstration of complement fixation in the Masugi kidney with labelled anticomplement].
    KLEIN P
    Allerg Asthmaforsch; 1961; 4():306-8. PubMed ID: 14456770
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the inhibitive effect of some substances on the properdin system-comparison with their anticomplement action].
    RYBAK M; PETAKOVA M; KOCI J
    Cesk Epidemiol Mikrobiol Imunol; 1962 Jan; 11():58-61. PubMed ID: 14495597
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of complement in experimental amyloidosis].
    Brécy H; Hartmannl
    Ann Biol Clin (Paris); 1967; 25(10):1089-107. PubMed ID: 5585001
    [No Abstract]   [Full Text] [Related]  

  • 8. [A simple method for removing anticomplement activity of sera].
    WIGAND R
    Z Immun exp ther; 1962 Dec; 124():368-9. PubMed ID: 14000599
    [No Abstract]   [Full Text] [Related]  

  • 9. [RESEARCH ON THE RELATION BETWEEN COMPLEMENT AND ANTICOMPLEMENT ACTIVITY IN CHILDREN].
    CICCIMARRA F
    Pediatria (Napoli); 1963; 71():660-8. PubMed ID: 14051038
    [No Abstract]   [Full Text] [Related]  

  • 10. [ANTICOMPLEMENT EFFECTS OF SERUM AND GAMMA-GLOBULIN].
    SCHIERZ G
    Z Immunitats Allergieforsch; 1964 Oct; 127():418-27. PubMed ID: 14323406
    [No Abstract]   [Full Text] [Related]  

  • 11. [Circulating immune complexes and the complement level in children with acute pneumonia].
    Popova OIa; Rodshteĭn OA; Kositskaia LS; Shteĭnlukht PL
    Ter Arkh; 1985; 57(5):42-5. PubMed ID: 2410992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Method for determining the anticomplement activity in immunoglobulin preparations].
    Kiseleva IA; Timofeeva GV
    Gematol Transfuziol; 1986 Apr; 31(4):54-7. PubMed ID: 3519357
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum immunoconglutinin levels in human amyloidosis and myelomatosis.
    Muckle TJ
    Ann Rheum Dis; 1968 Nov; 27(6):531-6. PubMed ID: 5728098
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoglobulins and complement C' 3 in lichen amyloidosus. Immunofluorescent study.
    Stringa SG; Bianchi C; Casala A; Bianchi O
    Arch Dermatol; 1972 Apr; 105(4):541-3. PubMed ID: 4111676
    [No Abstract]   [Full Text] [Related]  

  • 15. The presence of complements in amyloid plaques of Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker disease.
    Ishii T; Haga S; Yagishita S; Tateishi J
    Appl Pathol; 1984; 2(6):370-9. PubMed ID: 6400466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticomplement activity in human aqueous humor.
    Zheng XB; Peng Q; Sha L
    Ophthalmic Res; 1994; 26(4):200-1. PubMed ID: 7808728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticomplement activity of the serum of subjects with nasal ozena].
    CORBETTA L
    Arch Ital Otol Rinol Laringol; 1962; 73():639-45. PubMed ID: 14022965
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunological characterization of amyloid fibrils in tissue sections.
    Husby G; Natvig JB
    Clin Exp Immunol; 1972 Jul; 11(3):357-66. PubMed ID: 4114473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid myopathy presenting with rhabdomyolysis: evidence of complement activation.
    Rodolico C; Mazzeo A; Toscano A; Pastura C; Maimone D; Musumeci O; Musolino C; Vita G
    Neuromuscul Disord; 2006 Aug; 16(8):514-7. PubMed ID: 16919949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphological and biochemical structure, immunological properties and origin of amyloid in the light of recent studies].
    Rostropowicz-Denisiewicz ; Polowiec Z
    Reumatologia; 1972; 10(4):349-55. PubMed ID: 4118938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.